Lirim Shemshedini

Affiliations: 
Biology (Cell-Molecular Biology) The University of Toledo 
Area:
Molecular Biology
Google:
"Lirim Shemshedini"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Khatiwada P, Rimal U, Han Z, et al. (2024) MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer. Endocrine Oncology (Bristol, England). 4: e230017
Khatiwada P, Rimal U, Malla M, et al. (2023) Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation. Endocrine Oncology (Bristol, England). 3: e230010
Khatiwada P, Rimal U, Han Z, et al. (2023) The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes. Endocrinology. 164
Han Z, Rimal U, Khatiwada P, et al. (2022) Dual Acting Peptides Target EZH2 and AR: a New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer. Endocrinology
Khatiwada P, Kannan A, Malla M, et al. (2020) Androgen up-regulation of Twist1 gene expression is mediated by ETV1. Peerj. 8: e8921
Khatiwada P, Malla M, Shemshedini L. (2020) Abstract 2072: TM4SF3 interaction with AR or AR-V7 is important for the survival of prostate cancer cells Epidemiology
Zhou J, Gao S, Hsieh CL, et al. (2017) Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells. Plos One. 12: e0184088
Dayal S, Zhou J, Manivannan P, et al. (2017) RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells. International Journal of Molecular Sciences. 18
Bhansali M, Zhou J, Shemshedini L. (2015) TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins. Molecular Endocrinology (Baltimore, Md.). me20151075
Bhansali M, Shemshedini L. (2014) COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells. Molecular Endocrinology (Baltimore, Md.). 28: 834-45
See more...